Anxo Pharmaceutical Co., Ltd. (6677.TWO)

TWD 24.2

(-0.21%)

Annual Balance Sheets

(In TWD)
Breakdown 2023 2022 2021 2020 2019
Total Assets 2.21 Billion 1.97 Billion 1.91 Billion 1.91 Billion 1.9 Billion
Total Current Assets 978.28 Million 771.49 Million 704.77 Million 704.68 Million 6.52 Million
Cash And Short Term Investments 411.16 Million 262.02 Million 229.72 Million 222.53 Million 177.63 Million
Cash and Cash Equivalents 295.43 Million 241.32 Million 214.18 Million 207.76 Million 177.63 Million
Short Term Investments 115.73 Million 20.7 Million 15.54 Million 14.77 Million -
Net Receivables 249.71 Million 240.85 Million 232.55 Million 212.28 Million 192.86 Million
Inventory 283.86 Million 243.1 Million 238.88 Million 267.02 Million 210.53 Million
Other Current Assets 149.27 Million 46.22 Million 3.61 Million 2.83 Million 6.52 Million
Total Non-Current Assets 1.24 Billion 1.2 Billion 1.21 Billion 1.2 Billion 1.27 Billion
Net PPE 1.07 Billion 1.1 Billion 1.13 Billion 1.15 Billion 1.19 Billion
Good Will And Intangible Assets 40.38 Million 41.56 Million 40.91 Million 41.61 Million 53.77 Million
Good Will 36.61 Million 36.61 Million 36.61 Million 36.61 Million 36.61 Million
Intangible Assets 3.77 Million 4.95 Million 4.3 Million 5 Million 17.16 Million
Long-Term Investments -85.73 Million - - -13.77 Million -
Tax Assets 22.02 Million 18.74 Million 11.77 Million 7.44 Million -
Other Non Current Assets 184.55 Million 32.78 Million 21.81 Million 21.33 Million 20.98 Million
Other Assets - - - - 631.18 Million
Total Liabilities 1.01 Billion 1.14 Billion 1.08 Billion 1.1 Billion 1.22 Billion
Total Current Liabilities 486.71 Million 555.07 Million 472.84 Million 465.86 Million 524.1 Million
Account Payables 73.23 Million 93.07 Million 77.46 Million 75.46 Million 91.25 Million
Tax Payables 6.67 Million 6.75 Million 4.32 Million 2.09 Million -
Short Term Debt 288.14 Million 326.39 Million 289.33 Million 265.8 Million 308.32 Million
Deferred Revenue 120.6 Million 131.11 Million 101.74 Million 119.13 Million -
Other Current Liabilities 4.73 Million 4.48 Million 4.29 Million 5.45 Million 124.52 Million
Total Non Current Liabilities 528.61 Million 589.4 Million 614.2 Million 635.87 Million 696.93 Million
Long-Term Debt 499.69 Million 561.65 Million 594.1 Million 624.59 Million 669.82 Million
Deferred Revenue Non Current 28.16 Million 26.49 Million 18.08 Million 9.94 Million -
Deferred Tax Liabilities Non Current - - - - -
Other Non Current Liabilities 752 Thousand 1.26 Million 2.01 Million 1.34 Million 27.11 Million
Other Liabilities - - - - -
Total Equity 1.2 Billion 829.63 Million 831.94 Million 811.45 Million 688.78 Million
Stock Holders Equity 1.08 Billion 724.86 Million 732.95 Million 713.01 Million 597.55 Million
Common Stock 556.63 Million 481.63 Million 481.63 Million 458.7 Million 427.45 Million
Retained Earnings 43.66 Million 21.8 Million 36.28 Million 43.12 Million 28.46 Million
Accumulated other comprehensive income - - - - 13.84 Million
Common Stock Equity 1.08 Billion 724.86 Million 732.95 Million 713.01 Million 597.55 Million
Capital Lease Obligation 33.64 Million 45.07 Million 30.17 Million 10.39 Million 13.75 Million
Total Investments 30 Million 20.7 Million 15.54 Million 1 Million -
Total Debt 787.84 Million 888.04 Million 883.43 Million 890.4 Million 978.14 Million
Net Debt 492.4 Million 646.72 Million 669.25 Million 682.63 Million 800.51 Million

Balance Sheet Charts